Children with genetic disorders disease free following novel stem cell transplant
12/07/2015
Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, has...
New research points to which leukaemia patients will need intensive treatment
12/07/2015
Researchers have identified a genetic fault in some leukaemia patients that could be responsible for halving survival times after diagnosis compared to patients without the fault - an average...
Multiple myeloma: Takeda presents data from phase 3 TOURMALINE-MM1 study for NINLARO
12/07/2015
Takeda Pharmaceutical Company Limited has announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing...
Takeda UK Ltd has announced post-treatment follow up data from the pivotal phase 2 study of single-agent brentuximab vedotin for the treatment of relapsed or refractory Hodgkin lymphoma following...
Amgen have announced that The Lancet Oncology published results from the pivotal Phase 3 head-to-head ENDEAVOR study comparing Kyprolis® (carfilzomib) plus dexamethasone to Velcade®...
Personalizing cancer treatment with help from 'virtual tumors'
12/07/2015
Researchers are developing computer simulations that use specific genetic makeup of patients' cancer cells to predict likely responses of individual tumors to particular drugs.
Ibrutinib improves survival in untreated chronic leukemia better than chemo
12/07/2015
A randomized study of older patients with untreated CLL or small lymphocytic lymphoma finds the relative risk of death is 84% lower with ibrutinib than with chlorambucil.
New vaccine strategy better protects high-risk cancer patients from flu
12/07/2015
Yale Cancer Center researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza. The findings were presented Dec.
Chronic lymphocytic leukemia mutations suggest new uses of existing cancer drugs
12/07/2015
Genetic tests revealed mutations to help predict success of drugs originally developed for melanoma and breast cancer.
A new analysis indicates that certain characteristics may increase a breast cancer survivor's risk of developing leukemia after undergoing chemotherapy and/or radiation.